Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_assertion type Assertion NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_head.
- NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_assertion description "[Treatments with activin (1-100 ng/mL) resulted in a significant decrease in cell proliferation in both IOSE-29 and IOSE-29EC cells, although we have shown that it stimulated the growth of ovarian cancer cells and had no effect on normal OSE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_provenance.
- NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_assertion evidence source_evidence_literature NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_provenance.
- NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_assertion SIO_000772 11344217 NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_provenance.
- NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_assertion wasDerivedFrom befree-2016 NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_provenance.
- NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_assertion wasGeneratedBy ECO_0000203 NP317361.RA28pPSxpS2PpMxD6bIiE_K8lusqx6k_4B3HHVocTUSI0130_provenance.